↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Readers on

mendeley
128 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
JDRF Randomized Clinical Trial to Assess the Efficacy of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes: Research Design and Methods
Published in
Diabetes Technology & Therapeutics, August 2008
DOI 10.1089/dia.2007.0302
Pubmed ID
Authors

JDRF CGM Study Group

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 2%
Spain 2 2%
Italy 1 <1%
Belgium 1 <1%
Unknown 122 95%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 24 19%
Student > Ph. D. Student 15 12%
Student > Bachelor 14 11%
Student > Master 14 11%
Other 9 7%
Other 18 14%
Unknown 34 27%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 43 34%
Engineering 10 8%
Nursing and Health Professions 9 7%
Computer Science 5 4%
Agricultural and Biological Sciences 4 3%
Other 19 15%
Unknown 38 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2025.
All research outputs
#1,540,923
of 34,457,357 outputs
Outputs from Diabetes Technology & Therapeutics
#151
of 2,067 outputs
Outputs of similar age
#3,538
of 135,932 outputs
Outputs of similar age from Diabetes Technology & Therapeutics
#1
of 8 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,067 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 135,932 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them